These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 833873

  • 21. A marker and putative pathoantigen of Hodgkin's cells.
    Paietta E, Stockert RJ, Morell A, Racevskis J, Wiernik PH.
    Recent Results Cancer Res; 1989; 117():91-8. PubMed ID: 2690234
    [Abstract] [Full Text] [Related]

  • 22. Purification and characterization of a Hodgkin's and B cell-associated glycoprotein.
    Wan KR, Wang MJ, Taylor CR, Imam SA.
    Anticancer Res; 1999; 19(4B):3275-81. PubMed ID: 10652624
    [Abstract] [Full Text] [Related]

  • 23. Hodgkin's disease: evidence for a tumor-associated antigen.
    Order SE, Porter M, Hellman S.
    N Engl J Med; 1971 Aug 26; 285(9):471-4. PubMed ID: 4104348
    [No Abstract] [Full Text] [Related]

  • 24. Tumor-fetal antigens in Hodgkin's disease: an immunoelectrophoretic analysis.
    Chism SE, Order SE, Hellman S.
    Am J Roentgenol Radium Ther Nucl Med; 1973 Jan 26; 117(1):5-11. PubMed ID: 4734393
    [No Abstract] [Full Text] [Related]

  • 25. Radioimmunoassay for human thymus-leukemia-associated antigen.
    Chechik BE, Madapallimattam A, Gelfand EW.
    J Natl Cancer Inst; 1979 Mar 26; 62(3):465-70. PubMed ID: 310909
    [Abstract] [Full Text] [Related]

  • 26. A monoclonal antibody to an antigen present in cells from a patient with Hodgkin's disease.
    Veenstra H, Close P, Dowdle EB.
    S Afr Med J; 1987 Dec 05; 72(11):794-6. PubMed ID: 3317934
    [Abstract] [Full Text] [Related]

  • 27. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K, Mori N, Kojima M.
    Arch Pathol Lab Med; 1988 Feb 05; 112(2):139-42. PubMed ID: 3257383
    [Abstract] [Full Text] [Related]

  • 28. Antigenic analysis of the lymphomata.
    Order SE.
    Br J Cancer Suppl; 1975 Mar 05; 2():128-39. PubMed ID: 1101915
    [Abstract] [Full Text] [Related]

  • 29. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ, Claviez A, Kruse ML, Pollmann M, Buck F, Harder S, Tiemann M, Dörffel W, Parwaresch R.
    Clin Cancer Res; 2006 Aug 15; 12(16):4804-11. PubMed ID: 16914565
    [Abstract] [Full Text] [Related]

  • 30. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV, Advani SH, Gothoskar BP.
    Neoplasma; 1993 Aug 15; 40(2):87-91. PubMed ID: 8350960
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
    Imam A, Stathopoulos E, Taylor CR.
    Anticancer Res; 1990 Aug 15; 10(4):1095-104. PubMed ID: 1696446
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP, Papsidero LD, Nemoto T, Chu TM.
    Cancer Res; 1981 Jul 15; 41(7):2900-7. PubMed ID: 7018673
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N.
    Srp Arh Celok Lek; 1998 Jul 15; 126(3-4):97-100. PubMed ID: 9863363
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.